Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Slim Down Solution, D-Glucosamine Fat Absorption Claims Targeted By FTC

This article was originally published in The Tan Sheet

Executive Summary

Slim Down Solution, Madeira Management and related marketers of the Slim Down Solution and similar weight-loss supplements agree to immediately halt false and unsubstantiated claims for the products under a stipulated order for preliminary injunction filed by the Federal Trade Commission in West Palm Beach, Fla. federal court Jan. 22

You may also be interested in...

“Substantial” Weight-Loss Ad Claims Not Scientifically Verifiable – FTC Panel

Weight loss greater than one pound per week is not scientifically feasible with OTC drugs and dietary supplements, a panel of scientific and medical experts asserted

Supplements Claim Weight Loss Without Diet, Exercise In 55% Of FTC Sample

More than half of the dietary supplement ads reviewed in a recent study by Federal Trade Commission staff claimed to produce weight loss without a reduction in caloric intake or increased physical activity, according to an FTC report released Sept. 17

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts